See related article, pp. 26-35 Single photon emission computed tomography (SPECT) myocardial perfusion imaging (MPI) is a noninvasive test to diagnose coronary artery disease, stratify risk, predict outcomes, guide patient management, and control costs. 1-5 Over the past 30 years, successive technical innovations including, but not limited to, SPECT acquisition and ECG gating have granted myocardial perfusion imaging the status of a reliable, widely applicable, and increasingly useful technique. 6,7 Reflecting these benefits, MPI is widely used and its volume has grown rapidly worldwide over the past 2 decades, to approximately 15 to 20 million procedures annually. 8 Although SPECT MPI is widely used, it is also associated with a relatively high radiation dose. While there is a considerable worldwide variation, SPECT MPI has the highest per capita radiation dose of all medical tests, 9-11 contributing to approximately 10% of the cumulative radiation dose of medical procedures in the United States. 12 The authors of the IAEA Nuclear Cardiology Protocols Cross-Sectional Study (INCAPS) rightfully concluded that the significant relationship between best-practice implementation and lower doses